Bracco Diagnostics Inc. Makes New Syringe Packs Available for Use with EmpowerCTA® Computed Tomography Contrast Delivery Systems Business Wire MONROE TOWNSHIP, N.J. -- October 11, 2013 Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A, recently announced the availability of syringe packs with spikes, to be used when loading contrast and saline for delivery with power injectors in computed tomography (CT) suites. Bracco syringe packs are specifically designed for use with the EmpowerCTA and Empower CT contrast delivery systems, offering greater flexibility in contrast and saline preparation. According to Terry Heagy, Senior Device Business Manager, Bracco Diagnostics Inc., “These new syringe packs reduce opportunities for contamination, help reduce contrast mess and allow efficient contrast loading.” Heagy also noted that the new spikes work with all volumes of contrast and saline to promote workflow efficiencies and ease of use. In addition, Bracco syringe packs with spikes conform to the Joint Commission’s “Elements of Performance for Medication Management,” as it pertains to standards for hospitals safely preparing medications.* About EmpowerCTA The EmpowerCTA Contrast Injection System is a dual head injector, designed to optimize the delivery of iodinated X-ray contrast media and saline flush in the dual head configuration during computed tomography (CT) procedures. The EmpowerCTA Contrast Injection System is rated among the safest injectors in the industry and is used in major teaching institutions in the United States. The EmpowerCTA has a built-in estimated Glomerular Filtration Rate (eGFR) calculator and a fully integrated Extravasation Detection Accessory (EDA™). DISCLAIMER Not all products are available in all global markets. Please refer to your local distributor or agent. EmpowerCTA is designed for the vascular administration of contrast and flushing media in conjunction with computed tomography (CT) scanning of the body. The EDA is intended to detect extravasations of contrast media during powered CT contrast injections. EmpowerCTA and EmpowerCT are registered trademarks of Bracco Injeneering SA, registered in the United States. EDA is a registered trademark of Bracco Injeneering SA, registered in the United States. Bracco Diagnostics Inc., reserves the right to modify the specifications and features described herein, or discontinue manufacture of the product described at any time without prior notice or obligation. Please contact your authorized Bracco Injeneering SA representative for the most updated information. For additional information about Bracco’s products, and for full prescribing information, please visit http://imaging.bracco.com/us-en. If you have any questions or require additional information about any Bracco product, please contact Bracco Professional Services at 1-800-257-5181, option 2. About Bracco Imaging Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs. Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities: X-Ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), Nuclear Medicine through radioactive tracers, and Gastrointestinal Endoscopy. The diagnostic imaging offer is completed by several medical devices and advanced administration systems for contrast imaging products in the fields of radiology. The Company operates in over 90 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements. With an on-going research covering all key modalities, Bracco Imaging has a strong presence in key geographies: North America; Europe and Japan operating through the Joint Venture Bracco-Eisai Co., Ltd. The Company also operates in Brazil, South Korea, and China through the Joint Venture Bracco Sine Pharmaceutical Corp. Ltd. Operational investments have been made in order to achieve top quality and compliance with a sustainable eco-friendly production. Manufacturing activities are located in Italy, Switzerland, Japan, China and Germany. Bracco Imaging is an innovative Research and Development (R&D) player with an efficient process oriented approach and a track record of innovation in the diagnostic imaging industry. R&D activities are managed in the three Research Centres located in Italy, Switzerland and the USA. For additional information – Please Contact Kai Huang, Product Manager. Kai.Huang@diag.bracco.com - +1 (609) 514-2396. *Joint Commission 2013, Standard MM.05.01.07 – The hospital safely prepares medications. Contact: Press: Bracco Diagnostics Inc. Lakshmi Sundar, 609-514-2236 email@example.com
Bracco Diagnostics Inc. Makes New Syringe Packs Available for Use with EmpowerCTA® Computed Tomography Contrast Delivery
Press spacebar to pause and continue. Press esc to stop.